[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![newstart_2024 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1109532876310302721.png) Camus [@newstart_2024](/creator/twitter/newstart_2024) on x 311.2K followers
Created: 2025-07-15 21:19:52 UTC

Pfizer CEO Albert Bourla highlights the critical role of the U.S. biomedical research ecosystem—big pharma, biotechs, academia, and NIH—in driving innovation. While NIH funding is vital, he notes that private sector investment (like Pfizer’s $11B/year R&D) fuels most breakthroughs.

But recent U.S. policies, like drug price controls, have slashed biotech funding to historic lows, stifling innovation. Meanwhile, China’s pro-innovation policies, IP protection, and faster FDA-like approvals have surged their biotech growth. Now, China leads in new drug applications—a stark shift from just X years ago.

![](https://pbs.twimg.com/amplify_video_thumb/1945229082393763840/img/fmq9YsW8nTLkDXtz.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945231865637416979/c:line.svg)

**Related Topics**
[$11byear](/topic/$11byear)
[investment](/topic/investment)
[$pfe](/topic/$pfe)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/newstart_2024/status/1945231865637416979)